Delaware | 000-50976 | 01-0666114 |
(State or other jurisdiction | (Commission | (IRS Employer |
of incorporation) | File Number) | Identification Number) |
o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Huron Consulting Group Inc. | |||
(Registrant) | |||
Date: | February 22, 2016 | /s/ C. Mark Hussey | |
C. Mark Hussey | |||
Executive Vice President, Chief Operating Officer, Chief Financial Officer and Treasurer |
Exhibit Number | Description | |
99.1 | Press release, dated February 22, 2016 |
• | Revenues increased 12.9% to $185.1 million in Q4 2015 from $163.9 million in Q4 2014. |
• | Operating income increased 69.7% to $36.7 million in Q4 2015 from $21.6 million in Q4 2014. |
• | Adjusted EBITDA(6), a non-GAAP measure, increased 38.9% to $40.0 million in Q4 2015 from $28.8 million in Q4 2014. |
• | Diluted earnings per share from continuing operations increased to $1.44 in Q4 2015 compared to $0.44 in Q4 2014. |
• | Adjusted diluted earnings per share from continuing operations(6), a non-GAAP measure, increased 56.7% to $0.94 in Q4 2015 from $0.60 in Q4 2014. |
• | Revenues for full year 2015 increased 11.4% to $699.0 million from $627.7 million for full year 2014. |
• | Operating income for full year 2015 increased 17.2% to $103.5 million from $88.3 million for full year 2014. |
• | Adjusted EBITDA(6) for full year 2015 increased 25.9% to $139.3 million from $110.6 million for full year 2014. |
• | Diluted earnings per share from continuing operations for full year 2015 increased 33.7% to $2.74 from $2.05 for full year 2014. |
• | Adjusted diluted earnings per share from continuing operations(6) for full year 2015 increased 22.0% to $2.99 from $2.45 for full year 2014. |
• | Company provides full year 2016 revenue guidance in a range of $720.0 million to $760.0 million. |
Three Months Ended December 31, | |||||||
2015 | 2014 | ||||||
Amortization of intangible assets | $ | 8,011 | $ | 2,314 | |||
Restructuring charges | $ | 1,752 | $ | 1,977 | |||
Litigation and other gains | $ | (10,000 | ) | $ | — | ||
Non-cash interest on convertible notes | $ | 1,817 | $ | 1,733 | |||
Tax effect | $ | (623 | ) | $ | (2,409 | ) | |
Net tax benefit related to "check-the-box" election | $ | (12,336 | ) | $ | — |
Twelve Months Ended December 31, | |||||||
2015 | 2014 | ||||||
Amortization of intangible assets | $ | 28,696 | $ | 8,896 | |||
Restructuring charges | $ | 3,329 | $ | 2,811 | |||
Litigation and other gains, net | $ | (9,476 | ) | $ | (590 | ) | |
Non-cash interest on convertible notes | $ | 7,141 | $ | 2,139 | |||
Tax effect | $ | (11,698 | ) | $ | (5,302 | ) | |
Net tax (benefit) expense related to “check-the-box” election | $ | (12,336 | ) | $ | 1,161 |
Three Months Ended December 31, | Twelve Months Ended December 31, | ||||||||||||||
2015 | 2014 | 2015 | 2014 | ||||||||||||
Revenues and reimbursable expenses: | |||||||||||||||
Revenues | $ | 185,100 | $ | 163,917 | $ | 699,010 | $ | 627,686 | |||||||
Reimbursable expenses | 16,747 | 17,634 | 70,013 | 73,847 | |||||||||||
Total revenues and reimbursable expenses | 201,847 | 181,551 | 769,023 | 701,533 | |||||||||||
Direct costs and reimbursable expenses (exclusive of depreciation and amortization shown in operating expenses): | |||||||||||||||
Direct costs | 104,467 | 104,333 | 401,915 | 384,277 | |||||||||||
Amortization of intangible assets and software development costs | 4,686 | 1,225 | 16,788 | 4,590 | |||||||||||
Reimbursable expenses | 16,738 | 17,580 | 69,932 | 73,855 | |||||||||||
Total direct costs and reimbursable expenses | 125,891 | 123,138 | 488,635 | 462,722 | |||||||||||
Operating expenses and other operating (gains) losses: | |||||||||||||||
Selling, general and administrative expenses | 40,646 | 30,834 | 157,902 | 132,799 | |||||||||||
Restructuring charges | 1,752 | 1,977 | 3,329 | 2,811 | |||||||||||
Litigation and other gains, net | (10,000 | ) | — | (9,476 | ) | (590 | ) | ||||||||
Depreciation and amortization | 6,849 | 3,969 | 25,135 | 15,451 | |||||||||||
Total operating expenses and other operating (gains) losses | 39,247 | 36,780 | 176,890 | 150,471 | |||||||||||
Operating income | 36,709 | 21,633 | 103,498 | 88,340 | |||||||||||
Other income (expense), net: | |||||||||||||||
Interest expense, net of interest income | (4,342 | ) | (3,889 | ) | (18,136 | ) | (8,679 | ) | |||||||
Other income (expense), net | 185 | 100 | (1,797 | ) | 400 | ||||||||||
Total other expense, net | (4,157 | ) | (3,789 | ) | (19,933 | ) | (8,279 | ) | |||||||
Income from continuing operations before income tax expense | 32,552 | 17,844 | 83,565 | 80,061 | |||||||||||
Income tax expense | 50 | 7,876 | 21,670 | 33,059 | |||||||||||
Net income from continuing operations | 32,502 | 9,968 | 61,895 | 47,002 | |||||||||||
Income (loss) from discontinued operations, net of tax | (13,159 | ) | 2,825 | (2,843 | ) | 32,049 | |||||||||
Net income | $ | 19,343 | $ | 12,793 | $ | 59,052 | $ | 79,051 | |||||||
Net earnings per basic share: | |||||||||||||||
Net income from continuing operations | $ | 1.47 | $ | 0.45 | $ | 2.80 | $ | 2.10 | |||||||
Income (loss) from discontinued operations, net of tax | (0.59 | ) | 0.13 | (0.13 | ) | 1.42 | |||||||||
Net income | $ | 0.88 | $ | 0.58 | $ | 2.67 | $ | 3.52 | |||||||
Net earnings per diluted share: | |||||||||||||||
Net income from continuing operations | $ | 1.44 | $ | 0.44 | $ | 2.74 | $ | 2.05 | |||||||
Income (loss) from discontinued operations, net of tax | (0.58 | ) | 0.13 | (0.13 | ) | 1.40 | |||||||||
Net income | $ | 0.86 | $ | 0.57 | $ | 2.61 | $ | 3.45 | |||||||
Weighted average shares used in calculating earnings per share: | |||||||||||||||
Basic | 22,093 | 22,010 | 22,136 | 22,431 | |||||||||||
Diluted | 22,551 | 22,548 | 22,600 | 22,925 | |||||||||||
Comprehensive income: | |||||||||||||||
Net income | $ | 19,343 | $ | 12,793 | $ | 59,052 | $ | 79,051 | |||||||
Foreign currency translation gain (loss), net of tax | 2,018 | (883 | ) | 1,817 | (1,618 | ) | |||||||||
Unrealized gain (loss) on investment, net of tax | 300 | (402 | ) | 4,435 | (250 | ) | |||||||||
Unrealized gain (loss) on cash flow hedging instruments, net of tax | 240 | (114 | ) | (12 | ) | 10 | |||||||||
Other comprehensive income (loss) | 2,558 | (1,399 | ) | 6,240 | (1,858 | ) | |||||||||
Comprehensive income | $ | 21,901 | $ | 11,394 | $ | 65,292 | $ | 77,193 |
December 31, 2015 | December 31, 2014 | ||||||
Assets | |||||||
Current assets: | |||||||
Cash and cash equivalents | $ | 58,437 | $ | 256,872 | |||
Receivables from clients, net | 85,297 | 76,490 | |||||
Unbilled services, net | 56,527 | 84,206 | |||||
Income tax receivable | 406 | 8,016 | |||||
Deferred income taxes, net | — | 14,629 | |||||
Prepaid expenses and other current assets | 28,922 | 13,583 | |||||
Current assets of discontinued operations | — | 32,363 | |||||
Total current assets | 229,589 | 486,159 | |||||
Property and equipment, net | 28,888 | 30,691 | |||||
Long-term investment | 34,831 | 12,250 | |||||
Other non-current assets | 24,460 | 19,920 | |||||
Intangible assets, net | 94,992 | 21,729 | |||||
Goodwill | 751,400 | 514,591 | |||||
Non-current assets of discontinued operations | — | 70,574 | |||||
Total assets | $ | 1,164,160 | $ | 1,155,914 | |||
Liabilities and stockholders’ equity | |||||||
Current liabilities: | |||||||
Accounts payable | $ | 7,220 | $ | 10,804 | |||
Accrued expenses | 24,276 | 17,051 | |||||
Accrued payroll and related benefits | 80,839 | 105,522 | |||||
Current maturities of long-term debt | — | 28,750 | |||||
Deferred revenues | 19,086 | 12,469 | |||||
Current liabilities of discontinued operations | — | 1,780 | |||||
Total current liabilities | 131,421 | 176,376 | |||||
Non-current liabilities: | |||||||
Deferred compensation and other liabilities | 23,768 | 11,221 | |||||
Long-term debt, net of current portion | 311,993 | 327,852 | |||||
Deferred lease incentives | 9,965 | 12,671 | |||||
Deferred income taxes, net | 34,688 | 26,657 | |||||
Non-current liabilities of discontinued operations | — | 503 | |||||
Total non-current liabilities | 380,414 | 378,904 | |||||
Commitments and contingencies | |||||||
Stockholders’ equity | |||||||
Common stock; $0.01 par value; 500,000,000 shares authorized; 24,775,823 and 24,976,395 shares issued at December 31, 2015 and December 31, 2014, respectively | 241 | 241 | |||||
Treasury stock, at cost, 2,249,630 and 2,097,173 shares at December 31, 2015 and December 31, 2014, respectively | (103,734 | ) | (94,074 | ) | |||
Additional paid-in capital | 438,367 | 442,308 | |||||
Retained earnings | 313,866 | 254,814 | |||||
Accumulated other comprehensive income (loss) | 3,585 | (2,655 | ) | ||||
Total stockholders’ equity | 652,325 | 600,634 | |||||
Total liabilities and stockholders’ equity | $ | 1,164,160 | $ | 1,155,914 |
Twelve Months Ended December 31, | |||||||
2015 | 2014 | ||||||
Cash flows from operating activities: | |||||||
Net income | $ | 59,052 | $ | 79,051 | |||
Adjustments to reconcile net income to net cash provided by operating activities: | |||||||
Depreciation and amortization | 58,053 | 30,989 | |||||
Share-based compensation | 21,487 | 20,130 | |||||
Amortization of debt discount and issuance costs | 9,329 | 3,832 | |||||
Allowances for doubtful accounts and unbilled services | 1,025 | 5,918 | |||||
Deferred income taxes | 2,765 | 8,096 | |||||
Loss on sale of business | 2,303 | — | |||||
Changes in operating assets and liabilities, net of acquisitions and divestitures: | |||||||
(Increase) decrease in receivables from clients | (2,836 | ) | 30,072 | ||||
(Increase) decrease in unbilled services | 31,696 | (38,211 | ) | ||||
(Increase) decrease in current income tax receivable / payable, net | 8,818 | (10,773 | ) | ||||
(Increase) decrease in other assets | (14,742 | ) | 2,324 | ||||
Increase (decrease) in accounts payable and accrued liabilities | 7,679 | 9,164 | |||||
Increase (decrease) in accrued payroll and related benefits | (25,221 | ) | 8,835 | ||||
Increase (decrease) in deferred revenues | 4,859 | (2,974 | ) | ||||
Net cash provided by operating activities | 164,267 | 146,453 | |||||
Cash flows from investing activities: | |||||||
Purchases of property and equipment, net | (18,571 | ) | (25,913 | ) | |||
Investment in life insurance policies | (5,804 | ) | (1,775 | ) | |||
Purchases of businesses | (339,966 | ) | (53,971 | ) | |||
Purchases of convertible debt investment | (15,438 | ) | (12,500 | ) | |||
Capitalization of internally developed software costs | (866 | ) | — | ||||
Proceeds from note receivable | — | 328 | |||||
Proceeds from sale of business, net of cash sold | 108,487 | — | |||||
Net cash used in investing activities | (272,158 | ) | (93,831 | ) | |||
Cash flows from financing activities: | |||||||
Proceeds from exercise of stock options | — | 857 | |||||
Shares redeemed for employee tax withholdings | (7,154 | ) | (3,653 | ) | |||
Tax benefit from share-based compensation | 3,588 | 5,107 | |||||
Share repurchases | (34,591 | ) | (50,000 | ) | |||
Proceeds from borrowings under credit facility | 314,000 | 129,000 | |||||
Repayments on credit facility | (365,750 | ) | (154,000 | ) | |||
Proceeds from convertible senior notes issuance | — | 250,000 | |||||
Proceeds from sale of warrants | — | 23,625 | |||||
Payments for convertible senior note hedge | — | (42,125 | ) | ||||
Payments for debt issue costs | — | (7,346 | ) | ||||
Payments for capital lease obligations | (48 | ) | (79 | ) | |||
Deferred payments for purchase of property and equipment | — | (471 | ) | ||||
Deferred acquisition payment | — | (4,745 | ) | ||||
Net cash provided by (used in) financing activities | (89,955 | ) | 146,170 | ||||
Effect of exchange rate changes on cash | (589 | ) | (51 | ) | |||
Net (decrease) increase in cash and cash equivalents | (198,435 | ) | 198,741 | ||||
Cash and cash equivalents at beginning of the period | 256,872 | 58,131 | |||||
Cash and cash equivalents at end of the period | $ | 58,437 | $ | 256,872 |
Three Months Ended December 31, | Percent Increase (Decrease) | ||||||||||
Segment and Consolidated Operating Results (in thousands): | 2015 | 2014 | |||||||||
Huron Healthcare: | |||||||||||
Revenues | $ | 118,263 | $ | 109,476 | 8.0 | % | |||||
Operating income | $ | 47,440 | $ | 41,593 | 14.1 | % | |||||
Segment operating income as a percentage of segment revenues | 40.1 | % | 38.0 | % | |||||||
Huron Education and Life Sciences: | |||||||||||
Revenues | $ | 43,041 | $ | 38,116 | 12.9 | % | |||||
Operating income | $ | 8,789 | $ | 8,592 | 2.3 | % | |||||
Segment operating income as a percentage of segment revenues | 20.4 | % | 22.5 | % | |||||||
Huron Business Advisory: | |||||||||||
Revenues | $ | 23,795 | $ | 15,742 | 51.2 | % | |||||
Operating income | $ | 5,749 | $ | 1,954 | 194.2 | % | |||||
Segment operating income as a percentage of segment revenues | 24.2 | % | 12.4 | % | |||||||
All Other: | |||||||||||
Revenues | $ | 1 | $ | 583 | (99.8 | )% | |||||
Operating loss | $ | (64 | ) | $ | (833 | ) | (92.3 | )% | |||
Segment operating loss as a percentage of segment revenues | N/M | N/M | |||||||||
Total Company: | |||||||||||
Revenues | $ | 185,100 | $ | 163,917 | 12.9 | % | |||||
Reimbursable expenses | 16,747 | 17,634 | (5.0 | )% | |||||||
Total revenues and reimbursable expenses | $ | 201,847 | $ | 181,551 | 11.2 | % | |||||
Statements of Earnings reconciliation: | |||||||||||
Segment operating income | $ | 61,914 | $ | 51,306 | 20.7 | % | |||||
Items not allocated at the segment level: | |||||||||||
Other operating expenses and gains | 18,356 | 25,704 | (28.6 | )% | |||||||
Depreciation and amortization expense | 6,849 | 3,969 | 72.6 | % | |||||||
Total operating income | 36,709 | 21,633 | 69.7 | % | |||||||
Other expense, net | 4,157 | 3,789 | 9.7 | % | |||||||
Income from continuing operations before income tax expense | $ | 32,552 | $ | 17,844 | 82.4 | % | |||||
Other Operating Data (excluding All Other): | |||||||||||
Number of full-time billable consultants (at period end) (1): | |||||||||||
Huron Healthcare | 1,037 | 1,099 | (5.6 | )% | |||||||
Huron Education and Life Sciences | 478 | 418 | 14.4 | % | |||||||
Huron Business Advisory | 306 | 205 | 49.3 | % | |||||||
Total | 1,821 | 1,722 | 5.7 | % | |||||||
Average number of full-time billable consultants (for the period) (1): | |||||||||||
Huron Healthcare | 1,063 | 1,109 | |||||||||
Huron Education and Life Sciences | 474 | 417 | |||||||||
Huron Business Advisory | 302 | 207 | |||||||||
Total | 1,839 | 1,733 |
Three Months Ended December 31, | ||||||||
Other Operating Data (continued): | 2015 | 2014 | ||||||
Full-time billable consultant utilization rate (2): | ||||||||
Huron Healthcare | 82.7 | % | 78.6 | % | ||||
Huron Education and Life Sciences | 74.4 | % | 74.2 | % | ||||
Huron Business Advisory | 74.8 | % | 63.5 | % | ||||
Total | 79.2 | % | 75.7 | % | ||||
Full-time billable consultant average billing rate per hour (3): | ||||||||
Huron Healthcare | $ | 223 | $ | 262 | ||||
Huron Education and Life Sciences | $ | 233 | $ | 227 | ||||
Huron Business Advisory (4) | $ | 215 | $ | 248 | ||||
Total | $ | 224 | $ | 252 | ||||
Revenue per full-time billable consultant (in thousands): | ||||||||
Huron Healthcare | $ | 82 | $ | 92 | ||||
Huron Education and Life Sciences | $ | 77 | $ | 76 | ||||
Huron Business Advisory | $ | 76 | $ | 71 | ||||
Total | $ | 80 | $ | 86 | ||||
Average number of full-time equivalents (for the period) (5): | ||||||||
Huron Healthcare | 199 | 68 | ||||||
Huron Education and Life Sciences | 51 | 46 | ||||||
Huron Business Advisory | 9 | 11 | ||||||
Total | 259 | 125 | ||||||
Revenue per full-time equivalent (in thousands): | ||||||||
Huron Healthcare | $ | 155 | $ | 105 | ||||
Huron Education and Life Sciences | $ | 124 | $ | 144 | ||||
Huron Business Advisory | $ | 106 | $ | 96 | ||||
Total | $ | 147 | $ | 119 |
Twelve Months Ended December 31, | Percent Increase (Decrease) | ||||||||||
Segment and Consolidated Operating Results (in thousands): | 2015 | 2014 | |||||||||
Huron Healthcare: | |||||||||||
Revenues | $ | 446,887 | $ | 415,803 | 7.5 | % | |||||
Operating income | $ | 169,560 | $ | 159,015 | 6.6 | % | |||||
Segment operating income as a percentage of segment revenues | 37.9 | % | 38.2 | % | |||||||
Huron Education and Life Sciences: | |||||||||||
Revenues | $ | 167,933 | $ | 145,962 | 15.1 | % | |||||
Operating income | $ | 44,216 | $ | 36,131 | 22.4 | % | |||||
Segment operating income as a percentage of segment revenues | 26.3 | % | 24.8 | % | |||||||
Huron Business Advisory: | |||||||||||
Revenues | $ | 82,968 | $ | 62,840 | 32.0 | % | |||||
Operating income | $ | 19,263 | $ | 14,035 | 37.2 | % | |||||
Segment operating income as a percentage of segment revenues | 23.2 | % | 22.3 | % | |||||||
All Other: | |||||||||||
Revenues | $ | 1,222 | $ | 3,081 | (60.3 | )% | |||||
Operating loss | $ | (1,718 | ) | $ | (2,466 | ) | (30.3 | )% | |||
Segment operating loss as a percentage of segment revenues | N/M | N/M | |||||||||
Total Company: | |||||||||||
Revenues | $ | 699,010 | $ | 627,686 | 11.4 | % | |||||
Reimbursable expenses | 70,013 | 73,847 | (5.2 | )% | |||||||
Total revenues and reimbursable expenses | $ | 769,023 | $ | 701,533 | 9.6 | % | |||||
Statements of Earnings reconciliation: | |||||||||||
Segment operating income | $ | 231,321 | $ | 206,715 | 11.9 | % | |||||
Items not allocated at the segment level: | |||||||||||
Other operating expenses and gains | 102,688 | 102,924 | (0.2 | )% | |||||||
Depreciation and amortization expense | 25,135 | 15,451 | 62.7 | % | |||||||
Total operating income | 103,498 | 88,340 | 17.2 | % | |||||||
Other expense, net | 19,933 | 8,279 | 140.8 | % | |||||||
Income from continuing operations before income tax expense | $ | 83,565 | $ | 80,061 | 4.4 | % | |||||
Other Operating Data (excluding All Other): | |||||||||||
Number of full-time billable consultants (at period end) (1): | |||||||||||
Huron Healthcare | 1,037 | 1,099 | (5.6 | )% | |||||||
Huron Education and Life Sciences | 478 | 418 | 14.4 | % | |||||||
Huron Business Advisory | 306 | 205 | 49.3 | % | |||||||
Total | 1,821 | 1,722 | 5.7 | % | |||||||
Average number of full-time billable consultants (for the period) (1): | |||||||||||
Huron Healthcare | 1,085 | 1,070 | |||||||||
Huron Education and Life Sciences | 442 | 417 | |||||||||
Huron Business Advisory | 243 | 180 | |||||||||
Total | 1,770 | 1,667 |
Twelve Months Ended December 31, | ||||||||
Other Operating Data (continued): | 2015 | 2014 | ||||||
Full-time billable consultant utilization rate (2): | ||||||||
Huron Healthcare | 77.9 | % | 78.3 | % | ||||
Huron Education and Life Sciences | 75.5 | % | 71.3 | % | ||||
Huron Business Advisory | 75.0 | % | 68.0 | % | ||||
Total | 76.9 | % | 75.4 | % | ||||
Full-time billable consultant average billing rate per hour (3): | ||||||||
Huron Healthcare | $ | 217 | $ | 248 | ||||
Huron Education and Life Sciences | $ | 231 | $ | 219 | ||||
Huron Business Advisory (4) | $ | 228 | $ | 255 | ||||
Total | $ | 222 | $ | 242 | ||||
Revenue per full-time billable consultant (in thousands): | ||||||||
Huron Healthcare | $ | 313 | $ | 363 | ||||
Huron Education and Life Sciences | $ | 325 | $ | 292 | ||||
Huron Business Advisory | $ | 328 | $ | 330 | ||||
Total | $ | 318 | $ | 341 | ||||
Average number of full-time equivalents (for the period) (5): | ||||||||
Huron Healthcare | 179 | 60 | ||||||
Huron Education and Life Sciences | 43 | 43 | ||||||
Huron Business Advisory | 8 | 9 | ||||||
Total | 230 | 112 | ||||||
Revenue per full-time equivalent (in thousands): | ||||||||
Huron Healthcare | $ | 604 | $ | 461 | ||||
Huron Education and Life Sciences | $ | 574 | $ | 558 | ||||
Huron Business Advisory | $ | 408 | $ | 390 | ||||
Total | $ | 591 | $ | 493 |
(1) | Consists of our full-time professionals who provide consulting services and generate revenues based on the number of hours worked. |
(2) | Utilization rate for our full-time billable consultants is calculated by dividing the number of hours all of our full-time billable consultants worked on client assignments during a period by the total available working hours for all of these consultants during the same period, assuming a forty-hour work week, less paid holidays and vacation days. |
(3) | Average billing rate per hour for our full-time billable consultants is calculated by dividing revenues for a period by the number of hours worked on client assignments during the same period. |
(4) | The Huron Business Advisory segment includes the operations of Rittman Mead India, a business that we acquired in July 2015. Absent the impact of Rittman Mead India, the average billing rate per hour for Huron Business Advisory for the three and twelve months ended December 31, 2015 would have been $258 and $256, respectively. |
(5) | Consists of consultants who work variable schedules as needed by our clients, as well as other professionals who generate revenues primarily based on number of hours worked. Also includes our cultural transformation consultants within our Studer Group solution, which include coaches and their support staff, and full-time employees who provide software support and maintenance services to our clients. |
Three Months Ended December 31, | Twelve Months Ended December 31, | ||||||||||||||
2015 | 2014 | 2015 | 2014 | ||||||||||||
Revenues | $ | 185,100 | $ | 163,917 | $ | 699,010 | $ | 627,686 | |||||||
Net income from continuing operations | $ | 32,502 | $ | 9,968 | $ | 61,895 | $ | 47,002 | |||||||
Add back: | |||||||||||||||
Income tax expense | 50 | 7,876 | 21,670 | 33,059 | |||||||||||
Interest and other expenses | 4,157 | 3,789 | 19,933 | 8,279 | |||||||||||
Depreciation and amortization | 11,535 | 5,194 | 41,923 | 20,041 | |||||||||||
Earnings before interest, taxes, depreciation and amortization (EBITDA) (6) | 48,244 | 26,827 | 145,421 | 108,381 | |||||||||||
Add back: | |||||||||||||||
Restructuring charges | 1,752 | 1,977 | 3,329 | 2,811 | |||||||||||
Litigation and other gains, net | (10,000 | ) | — | (9,476 | ) | (590 | ) | ||||||||
Adjusted EBITDA (6) | $ | 39,996 | $ | 28,804 | $ | 139,274 | $ | 110,602 | |||||||
Adjusted EBITDA as a percentage of revenues (6) | 21.6 | % | 17.6 | % | 19.9 | % | 17.6 | % |
Three Months Ended December 31, | Twelve Months Ended December 31, | ||||||||||||||
2015 | 2014 | 2015 | 2014 | ||||||||||||
Net income from continuing operations | $ | 32,502 | $ | 9,968 | $ | 61,895 | $ | 47,002 | |||||||
Weighted average shares – diluted | 22,551 | 22,548 | 22,600 | 22,925 | |||||||||||
Diluted earnings per share from continuing operations | $ | 1.44 | $ | 0.44 | $ | 2.74 | $ | 2.05 | |||||||
Add back: | |||||||||||||||
Amortization of intangible assets | 8,011 | 2,314 | 28,696 | 8,896 | |||||||||||
Restructuring charges | 1,752 | 1,977 | 3,329 | 2,811 | |||||||||||
Litigation and other gains, net | (10,000 | ) | — | (9,476 | ) | (590 | ) | ||||||||
Non-cash interest on convertible notes | 1,817 | 1,733 | 7,141 | 2,139 | |||||||||||
Tax effect | (623 | ) | (2,409 | ) | (11,698 | ) | (5,302 | ) | |||||||
Net tax (benefit) expense related to “check-the-box” election | (12,336 | ) | — | (12,336 | ) | 1,161 | |||||||||
Total adjustments, net of tax | (11,379 | ) | 3,615 | 5,656 | 9,115 | ||||||||||
Adjusted net income from continuing operations (6) | $ | 21,123 | $ | 13,583 | $ | 67,551 | $ | 56,117 | |||||||
Adjusted diluted earnings per share from continuing operations (6) | $ | 0.94 | $ | 0.60 | $ | 2.99 | $ | 2.45 |
(6) | In evaluating the Company’s financial performance, management uses earnings before interest, taxes, depreciation and amortization (“EBITDA”), adjusted EBITDA, adjusted EBITDA as a percentage of revenues, adjusted net income from continuing operations, and adjusted diluted earnings per share from continuing operations, which are non-GAAP measures. Our management uses these non-GAAP financial measures to gain an understanding of our comparative operating performance (when comparing such results with previous periods or forecasts). These non-GAAP financial measures are used by management in their financial and operating decision making because management believes they reflect our ongoing business in a manner that allows for meaningful period-to-period comparisons. Management also uses these non-GAAP financial measures when publicly providing our business outlook, for internal management purposes, and as a basis for evaluating potential acquisitions and dispositions. We believe that these non-GAAP financial measures provide useful information to investors and others in understanding and evaluating Huron’s current operating performance and future prospects in the same manner as management does, if they so choose, and in comparing in a consistent manner Huron’s current financial results with Huron’s past financial results. Investors should recognize that these non-GAAP measures might not be comparable to similarly titled measures of other companies. These measures should be considered in addition to, and not as a substitute for or superior to, any measure of performance, cash flows or liquidity prepared in accordance with accounting principles generally accepted in the United States. |
Year Ending | |||||||
December 31, 2016 | |||||||
Guidance Range | |||||||
Low | High | ||||||
Projected revenues - GAAP | $ | 720.0 | $ | 760.0 | |||
Projected net income from continuing operations - GAAP | $ | 45.0 | $ | 50.0 | |||
Add back: | |||||||
Income tax expense | 31.0 | 35.0 | |||||
Interest and other expenses | 16.5 | 17.0 | |||||
Depreciation and amortization | 43.5 | 43.5 | |||||
Projected earnings before interest, taxes, depreciation and amortization (EBITDA) (7) | 136.0 | 145.5 | |||||
Add back: | |||||||
Restructuring charges | 2.0 | 2.0 | |||||
Projected adjusted EBITDA (7) | $ | 138.0 | $ | 147.5 | |||
Projected adjusted EBITDA as a percentage of projected revenues (7) | 19.2 | % | 19.4 | % |
Year Ending | |||||||
December 31, 2016 | |||||||
Guidance Range | |||||||
Low | High | ||||||
Projected net income from continuing operations - GAAP | $ | 45.0 | $ | 50.0 | |||
Projected diluted earnings per share from continuing operations - GAAP | $ | 2.10 | $ | 2.30 | |||
Add back: | |||||||
Amortization of intangible assets | 30.0 | 30.0 | |||||
Restructuring charges | 2.0 | 2.0 | |||||
Non-cash interest on convertible notes | 7.5 | 7.5 | |||||
Tax effect | (16.0 | ) | (16.0 | ) | |||
Total adjustments, net of tax | 23.5 | 23.5 | |||||
Projected adjusted net income from continuing operations (7) | $ | 68.5 | $ | 73.5 | |||
Projected adjusted diluted earnings per share from continuing operations (7) | $ | 3.20 | $ | 3.40 |
(7) | In evaluating the Company’s outlook, management uses projected EBITDA, projected adjusted EBITDA, projected adjusted EBITDA as a percentage of revenues, projected adjusted net income from continuing operations, and projected adjusted diluted earnings per share from continuing operations, which are non-GAAP measures. Management believes that the use of such measures, as supplements to projected net income and projected diluted earnings per share, and other GAAP measures, are useful indicators for investors. These useful indicators can help readers gain a meaningful understanding of the Company’s core operating results and future prospects without the effect of non-cash or other one-time items. Investors should recognize that these non-GAAP measures might not be comparable to similarly titled measures of other companies. These measures should be considered in addition to, and not as a substitute for or superior to, any measure of performance, cash flows or liquidity prepared in accordance with accounting principles generally accepted in the United States. |